Changes In Equity And Comprehensive Income Line Items [Line Items]

No definition available.

Name:	alt_ChangesInEquityAndComprehensiveIncomeLineItemsLineItems
Namespace Prefix:	alt_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Class of warrant or right exercise price of warrants or rights 2.

+ References

No definition available.

+ Details

Name:	alt_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights2
Namespace Prefix:	alt_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Class of warrant or right expiration period.

+ References

No definition available.

+ Details

Name:	alt_ClassOfWarrantOrRightExpirationPeriod
Namespace Prefix:	alt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Deemed dividend.

+ References

No definition available.

+ Details

Name:	alt_DeemedDividend
Namespace Prefix:	alt_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sale of stock, number of investors involved in transaction.

+ References

No definition available.

+ Details

Name:	alt_SaleOfStockNumberOfInvestorsInvolvedInTransaction
Namespace Prefix:	alt_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Date the subsidiary or equity investee issued or sold stock, in CCYY-MM-DD format.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockTransactionDate
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=alt_SpitfirePharmaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=alt_RegisteredDirectOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=alt_CommonUnitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=alt_PrefundedUnitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Common Stock - Additional Information (Detail)	Jul. 12, 2019 shares	Mar. 12, 2019 USD ($) Investor $ / shares shares	Sep. 30, 2019 USD ($)
Spitfire Pharma, Inc. [Member]
Changes In Equity And Comprehensive Income Line Items [Line Items]
Unregistered shares of common stock \| shares	1,887,250
Registered Direct Offering [Member]
Changes In Equity And Comprehensive Income Line Items [Line Items]
Sale of transaction date		Mar. 12, 2019
Number of institutional investors involved in offering \| Investor		2
Common units outstanding \| shares		1,500,000
Warrant expiration period		5 years
Net proceeds from offering \| $		$ 12,668,784
Deemed dividend \| $			$ 452,925
Registered Direct Offering [Member] \| Maximum [Member]
Changes In Equity And Comprehensive Income Line Items [Line Items]
Per share exercise price		$ 4.1798
Registered Direct Offering [Member] \| Minimum [Member]
Changes In Equity And Comprehensive Income Line Items [Line Items]
Per share exercise price		2.7568
Registered Direct Offering [Member] \| Common Units
Changes In Equity And Comprehensive Income Line Items [Line Items]
Public offering price per share		$ 3.21
Shares of common stock called by warrants \| shares		0.70
Per share exercise price		$ 3.21
Registered Direct Offering [Member] \| Pre-funded Units [Member]
Changes In Equity And Comprehensive Income Line Items [Line Items]
Common units outstanding \| shares		2,861,370
Public offering price per share		$ 3.20
Shares of common stock called by warrants \| shares		0.70
Per share exercise price		$ 3.21
Per share exercise price		$ 0.01